DH
Insider
Dawn Halkuff
DirectorDawn Halkuff (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $122K of XERS (20,000 sh × $6.09, as filed), executed Jun 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$122K
shares × price, as filed
Last traded
Jun 4
Filed Jun 5
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $431K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 0 buys · 2 sells
2 filings
Recent filings
XERSSALE
Xeris Biopharma Holdings, Inc.
View filing →
$122K20,000 sh × $6.09
Exec Jun 4
Filed Jun 5 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $309K
42,500 sh × $7.28
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET